Autologous Transplant Superior to CAR-T Therapy for Patients With Large B-Cell Lymphoma
The following is a summary of “Autologous Transplant (auto-HCT) Is Associated with Improved...
Read More
Meeting Coverage
Acalabrutinib Lenalidomide+Rituximab Treatment Achieves High CR Rates in Patients With Follicular Lymphoma
The following is a summary of “Addition of Acalabrutinib to Lenalidomide and Rituximab...
Read More
Interleukin Inhibitors Highly Effective for Patients With Psoriasis
April Armstrong, MD, MPH, spoke with Physician’s Weekly about the role of interleukin inhibitors, IL-17 and IL-23, in treating psoriasis.
Read More
Check Out the 65th ASH Annual Meeting Exhibit Hall
With over 275 exhibitors, the 65th ASH Annual Meeting exhibit hall is not to be missed!
Read More
Participate Virtually in the 2023 ASH Foundation Run/Walk
Sign up today for the virtual 2023 ASH Foundation Run/Walk!
Read More
Helpful Resources for Before, During & After the 65th ASH Annual Meeting
Make the most of your attendance at the 65th ASH annual meeting by utilizing these helpful resources to plan your schedule and stay informed!
Read More
Exploring the Efficacy and Safety of Acalabrutinib Treatment By Line of Therapy in CLL and/or SLL Patients
The following is a summary of “Real-World Effectiveness and Safety Outcomes of Acalabrutinib...
Read More
Real-World Characteristics, Biomarker Testing, & Adjuvant Therapy for Resected NSCLC
At 2023 NACLC, Xiaohan Hu presented “Real-World Patients Characteristics, Biomarker Testing & Adjuvant Therapy for Resected NSCLC at US Oncology Clinics, 2019-2023”
Read More
Radiation Therapy in Today’s NSCLC Era
At the 2023 NACLC, Benjamin Lok, MD, FRCPC, presented a radiation “mini-debate” focused on the “Goldie Locks Effect.”
Read More
Can AI Predict Lung Cancer on Chest Computed Tomography?
At the 2023 NACLC, Florian Fintelman, MD, presented a recap of data on the use of artificial intelligence for lung cancer risk prediction on chest CT.
Read More
2023 NACLC: Grab Lunch Here Before You Leave
Forget the O’Hare food kiosks and grab lunch at one of these locations instead, all within easy walking distance from the Chicago Marriott Downtown Magnificent Mile
Read More
Dr. Jonathan Spicer, 2023 NACLC Closing Keynote Speaker
Don’t miss the 2023 NACLC closing keynote—Perioperative Therapy—to be given by Jonathan Spicer, MD, PhD, 11:15 a.m.-12:15 p.m., Sunday, December 3, 2023.
Read More
2023 NACLC Sunday Schedule
Make the most of your final day at the 2023 NACLC conference—use the program information below to plan your schedule:
Read More
Curated ESMO 2023: eNSCLC eBook
A curated eBook featuring ESMO 2023: eNSCLC-focused studies, findings, and expert opinions.
Read More
Minorities Remain Underrepresented in DME Clinical Trials
Many barriers exist in the recruitment for diabetic macular edema clinical trials of patients of minority racial and ethnic backgrounds.
Read More
PIRA Represents Most Common Form of Disability Accrual in Relapsing-Remitting MS
Key risk factors for progression independent of relapse activity in relapsing-remitting MS include age and longer disease duration.
Read More
Q&A: Examining Emerging Therapies to Restore Function in CNS Diseases in MS
More targeted, higher efficacious medications can drastically reduce the risk for accruing disability in newly diagnosed patients with MS.
Read More
Explore the Magnificent Mile While Attending 2023 NACLC
2023 NACLC is taking place in Chicago’s famous “Magnificent Mile” district, so be sure to set aside a little time for exploring!
Read More
2023 NACLC Satellite CME Symposia Cover an Array of Topics
Check out the fascinating array of topics to be covered during 2023 NACLC satellite CME symposia!
Read More
2023 NACLC Program
The IASLC 2023 North America Conference on Lung Cancer (NACLC) runs December 1-3, 2023, at the...
Read More